Flora Peyvandi/X
Sep 29, 2025, 12:54
Microfluidic Technology Uncovers Ongoing TTP Disease Activity
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared a post on X:
“A microfluidic approach reveals ongoing disease activity in thrombotic thrombocytopenic purpura patients despite clinical remission”
Title: A microfluidic approach reveals ongoing disease activity in thrombotic thrombocytopenic purpura patients despite clinical remission
Authors: Adela Constantinescu-Bercu, Sabina McCann, Bertina Dragunaite, Raphael Sivera, Yishi Tan, Louisa Keogh, Karen Vanhoorelbeke, Heidi Rossmann, Bernhard Lämmle, Rens de Groot, Marie Scully
Read the full article here.
Stay updated with Hemostasis Today.
Adela Constantinescu-Bercu
Bernhard Lämmle
Bertina Dragunaite
Flora Peyvandi
Health
Heidi Rossmann
Hematology
Hemostasis
Hemostasis Today
Karen Vanhoorelbeke
Louisa Keogh
Marie Scully
Medicine
microfluidic approach
Raphael Sivera
Rens de Groot
Sabina McCann
Thrombotic thrombocytopenic purpura
Yishi Tan
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market
-
Feb 25, 2026, 16:25Tagreed Alkaltham: The Blood Banker Personality
-
Feb 25, 2026, 16:17Sanjay Ahuja: Insightful Talk on 100 Years of VWD by Jorge Di Paola
-
Feb 25, 2026, 15:20Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
-
Feb 25, 2026, 15:15Ajay Kumar: Plasma Component Quality Control Standards
-
Feb 25, 2026, 15:09Wolfgang Miesbach: Efficacy, Safety and Thrombosis Signals in Haemophilia A/B with Inhibitors